{
    "clinical_study": {
        "@rank": "126201", 
        "arm_group": [
            {
                "arm_group_label": "Hyaluronan", 
                "arm_group_type": "Experimental", 
                "description": "Hyaluronan acid Neovisc : one 6cc (viscosupplement) intra-articular injection"
            }, 
            {
                "arm_group_label": "Bupivacaine", 
                "arm_group_type": "Placebo Comparator", 
                "description": "one Marcain extra-capsular injection"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to assess the changes in daily physical activity and gait\n      pattern, following a viscosupplement injection among a population who is suffering from hip\n      osteoarthritis. A kinetic and kinematic gait analysis, an Actigraph activity monitor, a\n      functional Timed-Stair-Test and two questionnaires (Medical Outcome Study Short-Form36\n      (MOS-SF36), Hip disability and Osteoarthritis Outcome Score (HOOS)) about how the pathology\n      affects the quality of life, will be use."
        }, 
        "brief_title": "Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hip Osteoarthritis", 
        "condition_browse": {
            "mesh_term": [
                "Osteoarthritis", 
                "Osteoarthritis, Hip"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  From 45 years old to 65 years old\n\n          -  Clinically symptomatic moderate or severe hip osteoarthritis (T\u00f6nnis Grade II to III)\n\n          -  Capacity to keep steady upright position and walking during 15 minutes\n\n          -  Body mass index < 40kg/m2\n\n        Exclusion Criteria:\n\n          -  Bilateral hip osteoarthritis\n\n          -  No broken hip or leg during the last 12 months\n\n          -  Bone necrosis\n\n          -  Rheumatoid arthritis, articular chondrocalcinosis, metabolic bone disease, psoriasis,\n             gout, active infection\n\n          -  Per os corticosteroid treatment\n\n          -  Corticosteroid injection < 3 months\n\n          -  Viscosupplement injection < 6 months\n\n          -  Hypersensitivity to hyaluronic acid products\n\n          -  Planed surgery during study duration\n\n          -  Physical or mental disability to fill in questionnaires and/or to participate to\n             follow-up"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02086474", 
            "org_study_id": "INF-2014"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hyaluronan", 
                "description": "Intra-articular injection", 
                "intervention_name": "Hyaluronan", 
                "intervention_type": "Drug", 
                "other_name": "Hyaluronan acid : Neovisc\u00ae"
            }, 
            {
                "arm_group_label": "Bupivacaine", 
                "description": "Extra-capsular injection", 
                "intervention_name": "Bupivacaine", 
                "intervention_type": "Drug", 
                "other_name": "Bupivacaine: Marcaine\u00ae"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Hyaluronic Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "antoine.cantin-warren.1@ulaval.ca", 
                "last_name": "Antoine Cantin-Warren, B.Sc.", 
                "phone": "518-656-2131", 
                "phone_ext": "4920"
            }, 
            "facility": {
                "address": {
                    "city": "Quebec", 
                    "country": "Canada", 
                    "zip": "G1V 0A6"
                }, 
                "name": "Pavillon de l'\u00c9ducation Physique et des Sports - Universit\u00e9 Laval"
            }, 
            "investigator": {
                "last_name": "Antoine Cantin-Warren, B.Sc.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Daily Activity Quantification and Gait Pattern Analysis Before and After Intra-articular Injection of Viscosupplement Among Hip Osteoarthritis Patients", 
        "overall_contact": {
            "email": "Sylvie.Turmel@mail.chuq.qc.ca", 
            "last_name": "Sylvie Turmel, RN", 
            "phone": "418-524-4444", 
            "phone_ext": "16055"
        }, 
        "overall_official": [
            {
                "affiliation": "Laval University", 
                "last_name": "Antoine Cantin-Warren, B.Sc.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Laval University", 
                "last_name": "\u00c9tienne L. Belzile, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Laval University", 
                "last_name": "Philippe Corbeil, Ph.D.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Subtraction between maximum and minimum flexion measured with motion capture system during gait", 
                "measure": "Change in hip flexion-extension range of motion", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline at 6 months"
            }, 
            {
                "description": "Intensity and duration of the daily physical activity measured with pedometer", 
                "measure": "Change in daily physical activity", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline at 6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02086474"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Laval University", 
            "investigator_full_name": "Philippe Corbeil", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Questionnaires HOOS", 
                "measure": "Change in hip pain", 
                "safety_issue": "No", 
                "time_frame": "change from Baseline at 6 months"
            }, 
            {
                "description": "Questionnaires: MOS-SF36 and HOOS", 
                "measure": "Change in quality of life", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline at 6 months"
            }, 
            {
                "description": "Measured during 3D gait analysis", 
                "measure": "Change in walking cadence", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline at 6 months"
            }
        ], 
        "source": "Laval University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Laval University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}